Lundbeck will advance the IV formulation of the drug to Phase III trials after the successful Phase IIb trial.

AI-driven detection, analysis, and response that materially reduces security noise and response time for the mid-market ...

Boutique MedTech CRO gains access to unified eClinical platform with wholesale pricing, training, and joint marketing ...

PROPEL 3 successfully met the primary endpoint of change from baseline in AHV at Week 52 (p<0.0001)- Change from baseline in AHV was ...

We are seeing exploitation of SolarWinds Web Help Desk via CVE‑2025‑40551 and CVE‑2025‑40536 that can lead to domain compromise; here is how to patch, hunt, and mitigate now.

A coordinated reconnaissance campaign targeting Citrix NetScaler infrastructure over the past week used tens of thousands of ...

NEWARK, Del., Jan. 29, 2026 /PRNewswire/ -- Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced that expanded primary analysis results from the STOMP2 trial were ...

1 Department of Endocrinology, Yanbian University Hospital, Yanji, Jilin, China 2 Department of Pain, Yanbian University Hospital, Yanji, Jilin, China Background: Cervicogenic headache (CEH) is often ...

A comprehensive real-time analytics platform that processes e-commerce clickstream events with sub-second latency, providing live dashboards for conversion funnels, revenue tracking, and customer ...

ManageEngine, a division of Zoho Corporation and a leading provider of enterprise IT management solutions, today announced that it was named a Challenger in the 2026 Gartner Magic Quadrant™ for ...